Friday June 14, 2019 Change -0.15% Price $118.47
Chart period: 2019-03-15 - 2019-06-14




Will AMED stock price go up or down on Mon, 17 Jun 2019?


Amedisys Inc Forecast and Stock Analysis

Technical AMED stock analysis for Friday June 14, 2019.

Buy candidate since 2019-06-07 Gain 2.38%

Amedisys Inc fell by -0.15% in the last day ( Friday, 14th Jun 2019 ) from $118.65 to $118.47 During day the stock fluctuated 1.34% from a day low at $118.06 to a day high of $119.64. The price has risen in 7 of the last 10 days and is up by 5.48% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -96 663 shares and in total 189 220 shares bought and sold for approximately $22.42 million.

Quick summary:

  • 30 day high of the AMED stock price was $119.64 and low was $106.65.
  • 90 day high was $131.38 and low was $106.65.
  • 52 week high for the Amedisys Inc - $140.91 and low - $82.49.


Amedisys Inc lies the upper part of a wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $119.74 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -11.19% during the next 3 months and, with 90% probability hold a price between $92.17 and $106.34 at the end of this period.

Click here for today's Top 5 Trending Companies


Amedisys Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $117.03 and $115.25. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday June 13, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 73 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Amedisys Inc finds support from accumulated volume at $117.68.

Support: $117.68 Price: $118.47 Resistance: $119.88


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.58 (1.34%) between high and low. For the last week, the stock has had a daily average volatility of 2.26%.

The stock is overbought on RSI14 and lies in the upper part of the trend. Normally this will pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stoploss: $113.78 (-3.96%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 73 and this increases the risk substantially. There is a sell signal from pivot top found 1 days ago.)

2.26 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate Downgraded
Weaker Buy Today AMED ranks #1171 as BUY CANDIDATE #1171 Stronger Buy

Will AMED stock price go up or down on Mon, 17 Jun 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank